Announcements
PP&N PhD candidate Abukabda publishes on cardiovascular effects of TiO2 nanoparticles
Nano-sized particles of titanium dioxide (TiO2) are considered as valuable ultrafine whitening powders and are used in applications such as cosmetics, sunscreens, pharmaceuticals, and high-grade plastics. Alaeddin Abukabda and his research mentor, Dr. Tim Nurkiewicz of the WVU Department of Physiology, Pharmacology & Neuroscience, have recently published a paper in the journal Frontiers in Cardiovascular Medicine. Alaeddin studied rats exposed to nano-TiO2 particles and observed that extrapulmonary toxicity is most robust in the arterioles. He determined this using wire myography with larger arteries and pressure myography with arterioles. The mechanism is thought to be endothelium-dependent as the toxicity gradient was observed only in response to acetylcholine (and not sodium nitroprusside nor phenylephrine).
First-year medical students participate in summer research program at WVU
A group of first-year medical students are participating in the WVU Health Sciences Initiation to Research Opportunities (INTRO) summer program. The students were selected to spend nearly 10 weeks of their summer after the first year in medical school participating in either clinical or basic science research in a lab with a research mentor. They will receive a stipend of $4,000.
WVU cancer researcher participates in study that shows promising treatments for certain patients with advanced colorectal cancer
A group of cancer researchers, including Richard Goldberg, M.D., director of the WVU Cancer Institute, released a study today in the Journal of the American Medical Association comparing the results of combinations of chemotherapy delivered with targeted therapy drugs in the treatment of people with advanced colorectal cancer who had not received prior drug treatment for their advanced disease.
Defense Health Program, Funding Opportunities for Fiscal Year 2017
Defense Health Program
Southeast Regional IDeA Conference
West Virginia will host the Southeast Regional IDeA Conference on October 11-13, in Morgantown. Join researchers from across the Southeast Region of the United States to discuss best practices, concepts and ideas to enhance biomedical research. Represented states/ territories will include Arkansas, Louisianna, Kentucky, Mississippi, South Carolina, and West Virginia.
Southeast Regional IDeA Conference
West Virginia will host the Southeast Regional IDeA Conference on October 11-13, in Morgantown. Join researchers from across the Southeast Region of the United States to discuss best practices, concepts and ideas to enhance biomedical research. Represented states/ territories will include Arkansas, Louisianna, Kentucky, Mississippi, South Carolina, and West Virginia.
Southeast Regional IDeA Conference
West Virginia will host the Southeast Regional IDeA Conference on October 11-13, in Morgantown. Join researchers from across the Southeast Region of the United States to discuss best practices, concepts and ideas to enhance biomedical research. Represented states/ territories will include Arkansas, Louisianna, Kentucky, Mississippi, South Carolina, and West Virginia.
Coben named to lead WVU School of Public Health
Jeffrey Coben, MD, has been named dean of the West Virginia University School of Public Health. He will continue to serve the entire Health Sciences Center as associate vice president for health affairs.
New video highlights mission of the WVU Cancer Institute
This new video gives an overview on how the WVU Cancer Institute is providing the best cancer care possible. WVU Cancer Institute leaders Richard Goldberg, MD, director; Laura Gibson, PhD, deputy director; Hannah Hazard, MD, director of clinical services and surgeon in chief; and Stephenie Kennedy, EdD, associate director of cancer prevention and control share how the Institute is carrying out its mission: patient care, research, outreach, and education.